Varenicline decreases alcohol consumption in heavy-drinking smokers

RATIONALE: Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor (nAChR) modulates the rewarding effects of alcohol. The nAChR α4β2 subunit partial agonist varenicline (Chantix™), which is approved by the Food and Drug Administration for smoking cessation, also decrea...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitchell, Jennifer M., Teague, Candice H., Kayser, Andrew S., Bartlett, Selena E., Fields, Howard L.
Format: Artigo
Language:Inglês
Published: Springer-Verlag 2012
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438402/
https://ncbi.nlm.nih.gov/pubmed/22547331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-012-2717-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items